BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8987181)

  • 1. Technetium-99m-alendronate: a new radiopharmaceutical for bone scanning.
    Arteaga de Murphy C; Meléndez-Alafort L; Montoya-Molina C; Sepúlveda-Méndez J
    Arch Med Res; 1996; 27(4):481-3. PubMed ID: 8987181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiopharmacokinetic data for 99mTc-ABP--a new radiopharmaceutical for bone scanning: comparison with 99mTc-MDP.
    Arteaga de Murphy C; Meléndez-Alafort L; Montoya-Molina CE; Sepúlveda-Méndez J
    Nucl Med Biol; 1997 Jan; 24(1):27-33. PubMed ID: 9080472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the concept of non-radioactive unit-dosed reagent kits [cold unit doses (CUDs)] as an efficient and cost-saving method for 99mTc radiopharmaceutical preparation.
    Lerthirunwong C; Cheng KT; Hladik WB
    Int J Rad Appl Instrum B; 1992 Oct; 19(7):727-35. PubMed ID: 1399692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [99m-Tc alendronate as a new option in bone gammagraphy].
    Montoya-Molina CE; Sepúlveda-Méndez J; Arteaga-de-Murphy C; Meléndez-Alafort L; Rojas-Bautista JC; López-Alvarenga JC
    Rev Invest Clin; 1997; 49(5):373-7. PubMed ID: 9527697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Labelling of Re-ABP with 188Re for bone pain palliation.
    Arteaga de Murphy C; Ferro-Flores G; Pedraza-López M; Meléndez-Alafort L; Croft BY; Ramírez FM; Padilla J
    Appl Radiat Isot; 2001 Mar; 54(3):435-42. PubMed ID: 11214878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophoretic analysis of different technetium-99m (SnCl2) methylene diphosphonate complexes.
    Najafi A; Hutchison N
    J Nucl Med; 1985 May; 26(5):524-30. PubMed ID: 3157787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of a novel
    Song X; Wang Y; Zhang J; Jin Z; Zhang W; Zhang Y
    Chem Biol Drug Des; 2018 Feb; 91(2):545-551. PubMed ID: 28994250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radiopharmacokinetic and gammagraphic studies for calculating personalized dosimetry].
    Arteaga de Murphy C; Pedraza-López M; Ferro-Flores G; Montoya-Molina CE; Meléndez-Alafort L
    Rev Invest Clin; 2001; 53(3):228-34. PubMed ID: 11496710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 99mTc-labelled compounds prepared with sodium dithionite as reducing agent.
    Vilcek S; Kalincák M; Machán V
    Nuklearmedizin; 1981 Dec; 20(6):283-9. PubMed ID: 6460222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technetium-99m APD compared with technetium-99m MDP as a bone scanning agent.
    Degrossi OJ; Oliveri P; García del Río H; Labriola R; Artagaveytía D; Degrossi EB
    J Nucl Med; 1985 Oct; 26(10):1135-9. PubMed ID: 4045556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A convenient method for the preparation of 99mTc-labelled pentavalent DMSA and its evaluation as a tumour imaging agent.
    Babbar A; Kashyap R; Chauhan UP
    J Nucl Biol Med (1991); 1991; 35(2):100-4. PubMed ID: 1657203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro stability of 99Tcm bone scan preparations from different manufacturers measured by various radiopharmaceutical parameters.
    Pauwels EK; Feitsma RI
    Nucl Med Commun; 1984 Jul; 5(7):467-72. PubMed ID: 6099535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 99mTc-labelled Cu(I)-EHDP, a potential skeletal imaging agent.
    Agha NH; Al-Hilli AM; Hassen HA
    Nuklearmedizin; 1981 Dec; 20(6):299-304. PubMed ID: 6799937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid preparation and quality control method for technetium-99m-2-methoxy isobutyl isonitrile (technetium-99m-sestamibi).
    Hung JC; Wilson ME; Brown ML; Gibbons RJ
    J Nucl Med; 1991 Nov; 32(11):2162-8. PubMed ID: 1834815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radiochemical purity and stability of 99mTc-MDP for bone scintigraphy (author's transl)].
    Yoshino T; Watanabe N; Kawahara Y; Okada K; Nishimura I
    Radioisotopes; 1980 Aug; 29(8):398-400. PubMed ID: 6451900
    [No Abstract]   [Full Text] [Related]  

  • 16. Preliminary studies on (177)Lu-labeled sodium pyrophosphate (177Lu-PYP) as a potential bone-seeking radiopharmaceutical for bone pain palliation.
    Abbasi IA
    Nucl Med Biol; 2012 Aug; 39(6):763-9. PubMed ID: 22459337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilization of 99mTc-pyrophosphate injection with gentisic acid.
    Ballinger J; Der M; Bowen B
    Eur J Nucl Med; 1981 Apr; 6(4):153-4. PubMed ID: 6260499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A new radiopharmaceutical for bone imaging: experimental study of 99mTc-HEDTMP].
    Hu S; Deng H; Jiang S; Luo S; Lei Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Aug; 27(4):811-5. PubMed ID: 20842850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New diphosphonate compounds for skeletal imaging: comparison with methylene diphosphonate.
    Subramanian G; McAfee JG; Thomas FD; Feld TA; Zapf-Longo C; Palladino E
    Radiology; 1983 Dec; 149(3):823-8. PubMed ID: 6316414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal studies of 99mTc-i-PIDP: a new bone imaging agent.
    Wang Y; Luo S; Lin J; Qiu L; Cheng W; Zhai H; Nan B; Ye W; Xia Y
    Appl Radiat Isot; 2011 Sep; 69(9):1169-75. PubMed ID: 21507669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.